The combination of etanercept and methotrexate increases the effectiveness of treatment in active psoriasis despite inadequate effect of methotrexate therapy.
about
Adverse effects of biologics: a network meta-analysis and Cochrane overviewTumour necrosis factor inhibitor monotherapy vs combination with MTX in the treatment of PsA: a systematic review of the literatureBiologic therapies in the treatment of psoriasis: a comprehensive evidence-based basic science and clinical review and a practical guide to tuberculosis monitoring.Biologics in dermatologic therapy - an update.Effective and sustainable biologic treatment of psoriasis: what can we learn from new clinical data?Systemic methotrexate therapy for psoriasis: past, present and future.Use of biologic agents in combination with other therapies for the treatment of psoriasisEtanercept in the treatment of plaque psoriasisUpdate of the management of chronic psoriasis: new approaches and emerging treatment options.The possibilities and principles of methotrexate treatment of psoriasis - the updated knowledge.A randomized, double-blind, placebo-controlled study to evaluate the addition of methotrexate to etanercept in patients with moderate to severe plaque psoriasis.A Delphi Consensus Approach to Challenging Case Scenarios in Moderate-to-Severe Psoriasis: Part 2.Optimizing adalimumab treatment in psoriasis with concomitant methotrexate (OPTIMAP): study protocol for a pragmatic, single-blinded, investigator-initiated randomized controlled trial.The use of methotrexate in dermatology: a review.Combination therapy in psoriasis: an evidence-based review.A consensus report on appropriate treatment optimization and transitioning in the management of moderate-to-severe plaque psoriasis.Therapeutic strategies in psoriasis patients with psoriatic arthritis: focus on new agents.Biologic fatigue in psoriasis.Antidrug antibodies in psoriasis: a systematic review.Biological therapies for psoriasis.The risk of deep fungal infections during biologic therapy for psoriasis.The risk of herpes zoster during biological therapy for psoriasis and other inflammatory conditions.Immunogenicity of biologic treatments for psoriasis: therapeutic consequences and the potential value of concomitant methotrexate.A systematic review of the use of quality-of-life instruments in randomized controlled trials for psoriasis.Etanercept, improved dosage schedules and combinations in the treatment of psoriasis: an update.A dermatologist guide to immunogenicityBiologics combined with conventional systemic agents or phototherapy for the treatment of psoriasis: real-life data from PSONET registries.British Association of Dermatologists' guidelines for the safe and effective prescribing of methotrexate for skin disease 2016.Psoriatic erythroderma and hypothalamus-pituitary axis suppression due to misuse of systemic steroid: two challenging casesLow-dose methotrexate - a therapeutical kick in TNF-alpha antagonist treatment for recalcitrant psoriasis vulgaris.Patterns of combination therapy with alefacept for the treatment of psoriasis in Canada in the AWARE study.Etanercept use for psoriasis in Taiwan: a case series study.Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.German S3-guidelines on the treatment of psoriasis vulgaris (short version).Comparison of quality of life questionnaires and their correlation with the clinical course of patients with psoriasis.S3 - Guidelines on the treatment of psoriasis vulgaris (English version). Update.
P2860
Q24234197-676DB3C9-F88E-4765-A326-FAF7D850C647Q27012134-4FEB927C-8261-41CD-839A-EA6FD6AD21CCQ30412650-45382CC8-E0AE-4C60-B4E9-7BDAC6556CABQ33607620-7C05949E-ABD8-41D1-9DE7-E5571AD7AC9AQ34166896-C7B0CF05-B87D-465F-AF30-DA84396AF9F9Q34356265-B3E039A2-326C-484B-9C18-3EF7C3ADD524Q34553755-5671624F-F75B-4844-B34F-1442C7C8F805Q34620263-9CD52B4F-E94D-437D-A1B3-274DDEBC6823Q34620375-640850B5-857A-4BE0-A63A-E9375821540EQ34945967-1BED927D-FAA3-4865-920D-F33A7CA2CDD0Q36417100-6A2E8038-11BE-4D3D-911C-59C03B2445ABQ36434813-E43EC49C-7FE2-4D79-88BE-55AB58258468Q37620900-15A898E4-B8FC-4263-B060-778F0AD2FB50Q37981730-31D19F08-A4D0-44AE-AD0C-DE83BDB4F9CCQ38074846-783CB1EF-F409-46F7-B4B5-E2A1B264091BQ38084325-736C6CBF-1C6A-433B-B11A-922C699557CDQ38098466-3730CC8A-35F4-44E6-B50D-8437A7301CE4Q38123192-22DF3110-07E0-46DB-A557-7F724DA48162Q38151757-41380981-A5B9-4F86-821E-838646804FF6Q38155648-05D371F8-36BE-4B56-AD57-F132F5AF1E11Q38219217-CF63DD7B-48D0-4EAD-B08C-49DBE3FB9E0DQ38235809-3046E19F-96F8-480E-863F-BFE5E185E53EQ38473460-DC7B0476-B2CF-44FD-90E8-A6074FB738F1Q38858335-97FF51A8-5BE3-42DF-ABF4-8DCCEB5D47C7Q39180810-B6D710A9-5459-4700-8741-EE927B71FBACQ39297511-3B0C5D0E-D573-4BF1-83BB-6EA2A4D7976BQ40045451-B48D9AE3-9328-4504-A419-5DAF3C466133Q40590985-B349ED1A-EC3B-4D70-8BFC-7745A2F6A1B7Q42699058-252ACB58-5BDB-40B2-84DD-F9D6BCECE139Q43408664-AA8227A6-3F5B-4AA9-9925-AB67738F4DD5Q44669251-33FCBEA4-10A1-4B20-B540-C49B7A07EDB3Q46536030-30C14127-0E20-465E-918B-081E91932B03Q47260366-53732A4C-0168-4FA2-954E-382CD914BD7EQ48480123-1F337C80-67A7-4689-8F2E-5445809DB766Q51045870-22E2792D-14A7-448E-9487-4988E2188BD6Q52888818-DB07725C-09F3-4380-869F-1825190A85EA
P2860
The combination of etanercept and methotrexate increases the effectiveness of treatment in active psoriasis despite inadequate effect of methotrexate therapy.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
The combination of etanercept ...... ffect of methotrexate therapy.
@en
The combination of etanercept ...... ffect of methotrexate therapy.
@nl
type
label
The combination of etanercept ...... ffect of methotrexate therapy.
@en
The combination of etanercept ...... ffect of methotrexate therapy.
@nl
prefLabel
The combination of etanercept ...... ffect of methotrexate therapy.
@en
The combination of etanercept ...... ffect of methotrexate therapy.
@nl
P2093
P356
P1476
The combination of etanercept ...... ffect of methotrexate therapy.
@en
P2093
Anders Johannesson
Birgitta Claréus
Edvard Falk
Henrik Lorentzen
Nils-Jørgen Mørk
Seija-Liisa Karvonen
Siân Walker
Susanne Qvitzau
Timo Reunala
P304
P356
10.2340/00015555-0511
P577
2008-01-01T00:00:00Z